Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs NORRIS MEDICINES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA NORRIS MEDICINES SHUKRA PHARMA/
NORRIS MEDICINES
 
P/E (TTM) x 19.3 -7.1 - View Chart
P/BV x 14.1 - - View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   NORRIS MEDICINES
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
NORRIS MEDICINES
Mar-23
SHUKRA PHARMA/
NORRIS MEDICINES
5-Yr Chart
Click to enlarge
High Rs8933 266.8%   
Low Rs118 137.5%   
Sales per share (Unadj.) Rs53.78.4 642.3%  
Earnings per share (Unadj.) Rs4.0-1.7 -229.9%  
Cash flow per share (Unadj.) Rs5.7-1.1 -508.7%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.1-12.4 -185.5%  
Shares outstanding (eoy) m10.9610.00 109.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.5 37.6%   
Avg P/E ratio x12.4-11.8 -105.1%  
P/CF ratio (eoy) x8.8-18.5 -47.5%  
Price / Book Value ratio x2.2-1.7 -130.2%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m547207 264.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4423 191.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m58884 703.9%  
Other income Rs m120 8,550.0%   
Total revenues Rs m60084 716.9%   
Gross profit Rs m549 581.7%  
Depreciation Rs m186 291.7%   
Interest Rs m315 18.7%   
Profit before tax Rs m44-12 -372.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m06 6.3%   
Profit after tax Rs m44-17 -252.0%  
Gross profit margin %9.111.0 82.6%  
Effective tax rate %0.8-46.6 -1.7%   
Net profit margin %7.5-20.9 -35.8%  
BALANCE SHEET DATA
Current assets Rs m53149 1,078.7%   
Current liabilities Rs m42577 551.7%   
Net working cap to sales %18.0-33.3 -53.9%  
Current ratio x1.20.6 195.5%  
Inventory Days Days054 0.0%  
Debtors Days Days1,87348,053,407 0.0%  
Net fixed assets Rs m21977 283.8%   
Share capital Rs m3999 39.4%   
"Free" reserves Rs m214-224 -95.6%   
Net worth Rs m253-124 -203.3%   
Long term debt Rs m38184 20.5%   
Total assets Rs m750126 593.4%  
Interest coverage x16.80.2 8,212.3%   
Debt to equity ratio x0.1-1.5 -10.1%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %6.3-2.0 -317.0%  
Return on equity %17.414.1 123.9%  
Return on capital %16.25.1 316.6%  
Exports to sales %02.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA2 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m02 0.0%   
Fx outflow Rs m00-   
Net fx Rs m02 0.0%   
CASH FLOW
From Operations Rs m3212 264.2%  
From Investments Rs m-44NA 20,122.7%  
From Financial Activity Rs m49-12 -420.2%  
Net Cashflow Rs m370 184,200.0%  

Share Holding

Indian Promoters % 51.0 34.0 149.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.1 157.1%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 66.0 74.3%  
Shareholders   10,963 25,317 43.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs NORRIS MEDI.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs NORRIS MEDI. Share Price Performance

Period RELISH PHARMA NORRIS MEDI. S&P BSE HEALTHCARE
1-Day -2.00% 4.86% 1.18%
1-Month 18.32% -30.61% -0.75%
1-Year 528.10% 29.65% 61.82%
3-Year CAGR 229.50% 27.90% 18.16%
5-Year CAGR 114.18% 17.59% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the NORRIS MEDI. share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of NORRIS MEDI. the stake stands at 34.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of NORRIS MEDI..

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

NORRIS MEDI. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of NORRIS MEDI..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.